Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × gallium maltolate × 1 year × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 3 Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

talquetamab 2 ruxolitinib 2 Suspensions 2 Powders 2 Gemcitabine 2 3-Iodobenzylguanidine 2 zolbetuximab 1 zenocutuzumab 1 zanidatamab 1 venetoclax 1 ulixertinib 1 tucatinib 1 trametinib 1 tisagenlecleucel 1 tipifarnib 1 telisotuzumab vedotin 1 taletrectinib 1 talazoparib 1 sotorasib 1 selinexor 1 ribociclib 1 revumenib 1 pembrolizumab 1 patritumab deruxtecan 1 omburtamab I-131 1 omaveloxolone 1 nirogacestat 1 niraparib 1 mirdametinib 1 mifamurtide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡